推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 2019年9月19日，證監(jiān)會(huì)召開《并購(gòu)重組委2019年第40次工作會(huì)議》，審核天業(yè)通聯(lián)重大資產(chǎn)出售及發(fā)行股份購(gòu)買資產(chǎn)暨關(guān)聯(lián)交易事項(xiàng)。天業(yè)通聯(lián)已向中國(guó)證監(jiān)會(huì)上市公司監(jiān)管部出具了《并購(gòu)重組申請(qǐng)人保證不影響和干擾并購(gòu)重組審核委員會(huì)審核的承諾函》。天業(yè)通聯(lián)在2019年9月19日并購(gòu)重組委工作會(huì)議召開當(dāng)天停牌。
19日下午，證監(jiān)會(huì)網(wǎng)站發(fā)布《中國(guó)證券監(jiān)督管理委員會(huì)并購(gòu)重組委2019年第40次會(huì)議審核結(jié)果公告》，秦皇島天業(yè)通聯(lián)重工股份有限公司(發(fā)行股份購(gòu)買資產(chǎn))獲有條件通過(guò)！
公告的發(fā)布也意味著晶澳上市重組順利完成！
恭喜晶澳太陽(yáng)能順利上市，光伏行業(yè)又增加一家A股上市光伏企業(yè)！
交易方案概況顯示，天業(yè)通聯(lián)擬將全部置出資產(chǎn)注入全資子公司秦皇島天業(yè)通聯(lián)重工科技有限公司，并向華建興業(yè)交割重工科技100%股權(quán)，擬出售資產(chǎn)的預(yù)估值為12.70億元；同時(shí)，天業(yè)通聯(lián)擬發(fā)行股份購(gòu)買晶澳太陽(yáng)能100%的股權(quán)，標(biāo)的資產(chǎn)的預(yù)估值為75.00億元。
本次交易構(gòu)成重大資產(chǎn)重組、重組上市和關(guān)聯(lián)交易。本次交易完成后，晶澳太陽(yáng)能的全體股東將成為上市公司股東，上市公司的控股股東變更為晶泰福，上市公司的實(shí)際控制人變更為靳保芳。
